Metabolite profiling of Alzheimer's disease cerebrospinal fluid - Wikidata - wikimedia - TriplyDB

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

http://www.wikidata.org/entity/Q28480903

about

Recent advances in the application of metabolomics to Alzheimer's Disease Investigation of the Material Basis Underlying the Correlation between Presbycusis and Kidney Deficiency in Traditional Chinese Medicine via GC/MS Metabolomics A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.1H NMR Analysis of Cerebrospinal Fluid from Alzheimer's Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.Aspartic acid in the hippocampus: a biomarker for postoperative cognitive dysfunction Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.Comparative metatranscriptomics reveals kingdom level changes in the rhizosphere microbiome of plants.Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy.A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota.Rapid labeling of amino acid neurotransmitters with a fluorescent thiol in the presence of o-phthalaldehyde.Quantitative in vivo neurochemical profiling in humans: where are we now?Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease Alterations in metabolic pathways and networks in Alzheimer's disease Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder Metabolic profiling of Alzheimer's disease brains Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis.Biomarkers in Sporadic and Familial Alzheimer's Disease.New Perspectives on Alzheimer's Disease and Nutrition.The impact of stress and glucocorticoids on memory.Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?Field-Effect Biosensors for On-Site Detection: Recent Advances and Promising Targets.Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.Metabolic status of CSF distinguishes rats with tauopathy from controls.Metabolite profiling reveals the glutathione biosynthetic pathway as a therapeutic target in triple negative breast cancer.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses Amyloid β42 peptide is toxic to non-neural cells in Drosophila yielding a characteristic metabolite profile and the effect can be suppressed by PI3K.Comparative analysis of cerebrospinal fluid metabolites in Alzheimer's disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.High throughput multiorgan metabolomics in the APP/PS1 mouse model of Alzheimer's disease.

P2860

Q26828606-161DF1CE-2C0D-4E00-A659-4E217F30A74D Q28392735-96A23BAA-C109-473B-A658-BAEC2173165D Q30235315-F0B62990-9BCA-4157-A758-7288E0E2DBDB Q30779251-1A8E6767-1751-4CB7-92F0-FAEF3D44FB47 Q30845482-6E13DF46-FB5D-48A3-8042-B1EAF567E5DC Q30885784-73822797-1228-4815-A1CE-1CA569F920A0 Q31109560-D34B27C4-0DC8-44CA-A4E4-345929EE77CA Q33601031-83FF9289-A22E-4C94-AD15-B81F8C6D92EE Q33801596-E0586912-BD0B-4917-8592-1078579DCBC1 Q33813927-0AE17A22-B345-4479-8189-4642D024BDBC Q34095665-C97DCE32-D372-45F5-994A-6F8B662D9B5D Q34735142-3F605211-9154-4DDE-AF4F-E9DFEC98F6F2 Q34830182-BBA302EC-A8FA-4605-AF3E-0201A47CBE5A Q35885375-10BB5AA1-5627-41CD-8B64-2635FF86548F Q36095783-C12B5F7A-6576-46E6-8EA7-6A2780C91FB2 Q36163566-73A74C71-9142-48B7-AD98-E2F958643C76 Q36164792-A5F357F8-90FB-4F2A-8C32-44199A7A9E18 Q36177915-5B0D4F2A-19F2-4D88-8D9B-089AE7C912C9 Q36337525-849E2F53-FFBC-4F24-B93D-944C1A9A2EF6 Q36809735-6350FDF7-0A09-461D-BB2B-19F16E90876F Q36869854-95B5D805-7441-4ACA-9117-0371826D131D Q37072582-C553644E-1E38-44D2-95D4-5A462B1F3592 Q37297626-A1C1B43C-D0F4-463A-8693-7D1021596F21 Q37667680-4B569978-B9B8-48EC-ACC8-086AC59BEF37 Q38210117-3B288B58-7FD7-429E-A01D-0D73AC0C487B Q38401864-0B67BE0C-5C46-42B8-BAE3-326EB1403C8E Q38592041-80844680-0B9B-4E90-A71C-79E2312EA2A8 Q38592243-CDA6AFFE-A755-4704-AC12-77ED53FDA769 Q38623204-59723432-E986-468F-A4AB-C8B780AFE824 Q38734121-677F67E4-22DE-45FA-B8B3-F62EE7FEF5CD Q39162716-10B8C056-4B1F-4FB2-ADE9-F596ACECF309 Q40051019-75D34304-A056-4D88-B082-69FE2E638AC6 Q41196957-1BBBD614-519A-4377-8469-79529AF9FF50 Q41690749-30C6D9F1-E458-4434-AB24-0DD9D25DF6DC Q42516669-D011EF49-9EC7-46AB-83EE-4907F09FBF01 Q42655692-24A4A912-FA56-4ABE-9D49-4BE149E4E2D5 Q47151964-26A26736-9493-4E40-95CC-F2E40A1CCEBB Q47827523-25C776AD-F6B1-4371-802F-36EA4A4CB3A8 Q47972723-51A74050-FA0C-4720-953A-613D9F8E037E Q48349422-60D07EF6-A73A-475F-B0D5-1C0C35FB512E

P2860

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

http://www.wikidata.org/entity/Q28480903

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@ast

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@en

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@nl

type

label

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@ast

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@en

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@nl

prefLabel

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@ast

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@en

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@nl

P1433

Q28480903-38634FF5-4306-4660-8C03-2DA16F7B6E48

P1476

Q28480903-29CC0BAF-442C-44D4-B9B6-1484357B377A

P2093

Q28480903-117DCC7A-8C03-4496-9F91-BD1382804AA4

Q28480903-3F436539-ED4B-4BAB-A8DB-C9EC304499FD

Q28480903-681EDFC1-B9AC-4DD2-A196-9CA502AE34DC

Q28480903-77E7534C-A93C-4308-9D9F-D820EDDD3E4E

Q28480903-A05DF6CC-113D-42DE-B5D3-D6B34D94D132

Q28480903-CF070364-AC87-4B2E-A5C7-309D88B90079

Q28480903-D21DA931-11ED-41AE-830F-A34761ED4A6D

P2860

Q28480903-0B7FD2DF-49EB-484D-87E6-6322C3862C66

Q28480903-2836F6C3-EBE1-435B-8A4C-89C4A8B36F55

Q28480903-284B591E-2972-43F9-BB13-1F6256EC2264

Q28480903-2C2D8247-BE0A-49CD-AA2B-D4AD601F4091

Q28480903-307AE7F5-96BF-4F13-9EB0-254316B7ABF9

Q28480903-32D0BBB2-7455-4CDE-AF10-CA936921A689

Q28480903-3517492D-7598-400E-BB1F-6A53782F96CD

Q28480903-3997E657-B953-43D7-8E58-9519DE14E9F0

Q28480903-3C599C07-2C03-4C52-8665-3C78136800AB

Q28480903-42FE8CAD-4585-4659-AC8F-1D234FC3597F

P304

Q28480903-E790FF35-E491-46C5-851D-D2749C10E0DF

P31

Q28480903-DADF21D1-05A3-4CE1-B79D-667BD04BD8F0

P3181

Q28480903-215F3635-C502-4AB5-8CDC-3C371F12706B

P356

Q28480903-EFA8B6CE-9224-4FD5-B2F2-5262C428F9AC

P407

Q28480903-CAAA12D4-45EB-43FC-A39A-8ED6745096AA

P433

Q28480903-A4977B18-145D-426E-82A2-18172A8C106C

P478

Q28480903-D0F7C60B-4528-49D3-A0BA-6E6D878D9F4C

P50

Q28480903-6F8A99B3-315D-4C4E-A118-58A541A6D1C4

Q28480903-B40BFC2F-E71E-409E-901F-C856ABFE4370

P577

Q28480903-AC768285-BC30-4778-8642-6F08F21D310D

P5875

Q28480903-80842458-6157-4790-A177-F00F9898274B

P698

Q28480903-D08E07AC-2FD3-4553-994E-E7C9A0A3B91B

P921

Q28480903-78045655-B736-4D9F-8FF8-95F83F6F7F31

Q28480903-A7CB4905-263A-4A20-B25C-B24FC5910969

P932

Q28480903-B1B8054E-1CF3-4B3B-BDBB-B4A336272D67

P3181

P356

JOURNAL.PONE.0031501

P1433

P1476

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

@en

P2093

Hans Senn

http://www.w3.org/2001/XMLSchema#string

Jan Wiemer

http://www.w3.org/2001/XMLSchema#string

Jürgen Kastler

http://www.w3.org/2001/XMLSchema#string

Kristina Busch

http://www.w3.org/2001/XMLSchema#string

Oliver Schmitz

http://www.w3.org/2001/XMLSchema#string

Peter Berndt

http://www.w3.org/2001/XMLSchema#string

Veronique Most

http://www.w3.org/2001/XMLSchema#string

P2860

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The cholinergic hypothesis of geriatric memory dysfunction

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Vascular and metabolic dysfunction in Alzheimer's disease: a review.

Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

P304

e31501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

632038

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0031501

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Christian Czech

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221856089

http://www.w3.org/2001/XMLSchema#string

P698

22359596

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

3281064

http://www.w3.org/2001/XMLSchema#string